Supporting prostate cancer focal therapy: a multidisciplinary International Consensus of Experts (“ICE”)

References

• Stamen TA, Freiha FS, MC Neal JE, et al. Localized Prostate cancer. Relationship of tumor volume to clinical significance fotr treatment of prostate cacer. Cancer 1993;71:933–8
   PubMedGoogle Scholar
• Ahmed H. The index Lesion and the origin of the prostate cancer. N Eng J Med 2009;361:1704--6
   PubMed Web of Science ®Google Scholar
• Karavitakis M, Winkler M, Abel P, et al. Histological characteristics of the index lesion in whole mountain radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis 2001;14:46–52
   Google Scholar
• Van der Kwast TH, Amin MB, Billis A, et al. International Society of Urological Pathology (ISUP) consensus conference on handling and staging of RP specimens. Working Group 2: T2 substaging and prostate cancer volume. Mod Pathol 2011;24:16--25
   PubMed Web of Science ®Google Scholar
• Liu W, Laitinen S, Khan S, et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009;15:559–65
   PubMed Web of Science ®Google Scholar
• De la Rosete, Ahmed H, Barentsz J, et al. Focal Therapy in prostate cancer-report from a consensus panel. J Endourol 2012;24:775–80
   Google Scholar
• Billis A, Meirelles LR, Freitas LL, et al. Prostate total tumor extent versus index tumor extent--which is predictive of biochemical recurrence following radical prostatectomy? J Urol 2013;189:99–104
   PubMedGoogle Scholar
• Karavitakis M, Ahmed HU, Abel PD, et al. Margin status after laparoscopic radical prostatectomy and the index lesion: implications for preoperative evaluation of tumor focallity in prostate cancer. J Endourol 2012;26:503–8
   PubMedGoogle Scholar
• Ukimura O, Abreu ALC, Gill IS, et al. Imagem visibility to enhance targeting precision and spatial mapping biopsy for focal therapy of prostate cancer. BJU Int 2013;111:E354–65
   Google Scholar
• Rosenkrantz AB, Deng FM, Kim S, et al. Prostate cancer: multiparametric MRI for index lesion localization--a multiple-reader study. AJR Am J Roentgenol 2012;199:830–7
   PubMedGoogle Scholar
• Simon RJ Bott, Hashim U Ahmed, Richard G Hindley, et al. The index lesion and focal therapy an analysis of the pathological characteristics of prostate cancer. BJU Int 2010;106:1607–11
   PubMedGoogle Scholar
• Haffner MC, Mosbruger T, Esopi DM, et al. Tracking the clonal origin of lethal prostate cancer. J Clin Invest 2013;123:4918–22
   PubMed Web of Science ®Google Scholar
• Dickinsons L, Ahmed HU, Kirkham AP, et al. A multicenter prospective development study using high intensity focused ultrasound for localized prostate cancer. Contemp Clin Trials 2013;36:68–80
   PubMedGoogle Scholar
• Epstein JI. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens. J Urol 2011;186:790–7
   PubMed Web of Science ®Google Scholar
• Eichelberger LE, Koch MO, Daggy JK, et al. Predicting tumor volume in radical prostatectomy specimens from patients with prostate cancer. Am J Clin Pathol 2003;120:386–9
   PubMed Web of Science ®Google Scholar
• Mouraviev V, Villers A, Bostwick DG, et al. Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-spearing prostate cancer therapies: active surveillance and focal targeted therapy. BJU Int 2011;108:1074–85
   PubMedGoogle Scholar
• Noguchi M, Stamey TA, McNeal JE, Nolley R. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol 2003;170:459–63
   PubMed Web of Science ®Google Scholar
• Billis A, Magna LA, Ferreira U. Correlation between tumor extent in radical prostatectomies and preoperative PSA, histological grade, surgical margins, and extraprostatic extension: application of a new practical method for tumor extent evaluation. Int Braz J Urol 2003;29:113–9
   PubMedGoogle Scholar
• Turkbey B, Pinto PA, Choyke PL. Imaging techniques for prostate cancer: implications for focal therapy. Nat Rev Urol 2009;6:191–203
   PubMedGoogle Scholar
• Turkbey B, Mani H, Shah V, et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011;186:1818–24
   PubMed Web of Science ®Google Scholar
• Guzzo TJ, Resnick MJ, Canter DJ, et al. Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance. Urol Oncol 2012;30:301–5
   PubMedGoogle Scholar
• Shukla-Dave A, Hricak H, Akin O, et al. Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. BJU Int 2012;109:1315–22
   PubMedGoogle Scholar
• Turkbey B, Mani H, Aras O, et al. Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 2013;268:144–52
   PubMed Web of Science ®Google Scholar
• Reis LO, Mendonça G, Menezes O, et al. Core biopsy length impacts gleason upgrading on radical prostatectomy. Urology 2013;82:S286
   Google Scholar
• Scattoni V, Zlotta A, Montironi R, et al. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol 2007;52:1309–22
   PubMed Web of Science ®Google Scholar
• Fuganti PE, Tobias-Machado M, Pinto MA, et al. Twelve core biopsy versus six systematic sextant biopsies. Braz J Urol 2002;28::207–13
   Google Scholar
• Lawrentschuk N, Haider MA, Daljeet N, et al. Prostatic evasive anterior tumours: the role of magnetic resonance imaging. BJU Int 2010;105:1231–6
   PubMed Web of Science ®Google Scholar
• Barqawi AB, Rove KO, Gholizadeh S, et al. The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer. J Urol 2011;186:80–5
   PubMedGoogle Scholar
• Franiel T, Stephan C, Erbersdobler A, et al. Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding–multiparametric MR imaging for detection and biopsy planning. Radiology 2011;259:162–72
   PubMed Web of Science ®Google Scholar
• Hambrock T, Somford DM, Hoeks C, et al. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 2010;183:520–7
   PubMed Web of Science ®Google Scholar
• Turkbey B, Shah VP, Pang Y, et al. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 2011;258:488–95
   PubMed Web of Science ®Google Scholar
• Villers A, Puech P, Mouton D, et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 2006;176:2432–7
   PubMed Web of Science ®Google Scholar
• Puech P, Potiron E, Lemaitre L, et al. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. Urology 2009;74:1094–9
   PubMed Web of Science ®Google Scholar
• Lemaitre L, Puech P, Poncelet E, et al. Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings. Eur Radiol 2009;19:470–80
   PubMedGoogle Scholar
• Puech P, Huglo D, Petyt G, et al. Imaging of organ-confined prostate cancer: functional ultrasound, MRI and PET/computed tomography. Curr Opin Urol 2009;19:168–76
   PubMedGoogle Scholar
• Kilinç R, Doluoglu OG, Sakman B, et al. The Correlation between diffusion-weighted imaging and histopathological evaluation of 356 prostate biopsy sites in patients with prostatic diseases. ISRN Urol 2012;2012:252846
   PubMedGoogle Scholar
• Salomon G, Schiffmann J. Real-time elastography for the detection of prostate cancer. Curr Urol Rep 2014;15:392
   PubMedGoogle Scholar
• Simmons LA, Ahmed HU, Moore CM, et al. The PICTURE study – Prostate Imaging (multi-parametric MRI and Prostate HistoScanning™) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation. Contemp Clin Trials. 2014;37:69–83
   PubMed Web of Science ®Google Scholar